Literature DB >> 31468359

Physiological and Therapeutic Roles of Neuropeptide Y on Biological Functions.

Pravin Shende1, Drashti Desai2.   

Abstract

Neuropeptide Y (NPY), an amino acid, used for various physiological processes for management and treatment of various ailments related to central nervous system, cardiovascular system, respiratory system, gastro-intestinal system and endocrinal system. In nasal mucosa, high concentrations of NPY are stored with noradrenaline in sympathetic nerve fibers. NPY Y1 receptor mediates nitric oxide levels and reduction in blood flow in nasal mucosa of the human. NPY plays a role in dietary consumption via various factors like signaling the CNS for a prerequisite of energy in hypothalamus by mediating appetite and shows orexigenic effect. NPY emerges as a natural ligand of G-protein coupled receptors which activates the Y-receptors (Y1-Y6). But applications of NPY are limited due to shows the cost inefficiency and stability issues in the formulation design and development. In this review, authors present the findings on various therapeutic applications of NPY on different organ systems. Moreover, its role in food intake, sexual behavior, blood pressure, etc. by inhibiting calcium and activating potassium channels. The combination therapies of drugs with neuropeptide Y and its receptors will show new targets for treating diseases. Further evaluation and detection of NPY needs to be investigated for animal models of various diseases like retinal degeneration and immune mechanisms.

Entities:  

Keywords:  Anxiety; Brain; Depression; Obesity; Stress

Mesh:

Substances:

Year:  2020        PMID: 31468359     DOI: 10.1007/5584_2019_427

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  49 in total

Review 1.  Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.

Authors:  Y Dumont; J C Martel; A Fournier; S St-Pierre; R Quirion
Journal:  Prog Neurobiol       Date:  1992       Impact factor: 11.685

2.  A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action.

Authors:  Verena M Ahrens; Katja B Kostelnik; Robert Rennert; David Böhme; Stefan Kalkhof; David Kosel; Lutz Weber; Martin von Bergen; Annette G Beck-Sickinger
Journal:  J Control Release       Date:  2015-04-30       Impact factor: 9.776

Review 3.  Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.

Authors:  Helen M Cox
Journal:  Auton Neurosci       Date:  2006-11-30       Impact factor: 3.145

Review 4.  Neuropeptide Y family of hormones: receptor subtypes and antagonists.

Authors:  A A Balasubramaniam
Journal:  Peptides       Date:  1997       Impact factor: 3.750

Review 5.  Clinical potentials of neuropeptide Y family of hormones.

Authors:  Ambikaipakan Balasubramaniam
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

Review 6.  Neuropeptide Y and epilepsy: recent progress, prospects and controversies.

Authors:  S C Baraban
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

Review 7.  Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.

Authors:  Joana Duarte-Neves; Luís Pereira de Almeida; Cláudia Cavadas
Journal:  Neurobiol Dis       Date:  2016-07-25       Impact factor: 5.996

Review 8.  Neuropeptide Y: An Anti-Aging Player?

Authors:  Mariana Botelho; Cláudia Cavadas
Journal:  Trends Neurosci       Date:  2015-11       Impact factor: 13.837

Review 9.  Neuropeptide Y and its role in CNS disease and repair.

Authors:  M Decressac; R A Barker
Journal:  Exp Neurol       Date:  2012-09-27       Impact factor: 5.330

10.  Neuropeptide Y and Epilepsy.

Authors:  William F. Colmers; Bouchaïb El Bahh
Journal:  Epilepsy Curr       Date:  2003-03       Impact factor: 7.872

View more
  12 in total

Review 1.  Hormone-like conopeptides - new tools for pharmaceutical design.

Authors:  Ashlin Turner; Quentin Kaas; David J Craik
Journal:  RSC Med Chem       Date:  2020-09-24

2.  Altered features of neurotransmitters: NPY, α-MSH, and AgRP in type 2 diabetic patients with hypertension.

Authors:  Baoxin Li; Shuang Ma; Shuqin Guo; Na Li; Dandan Liu; He Wang; Na Zhai; Yunliang Zhang
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

3.  Involvement of Neuropeptide Y within Paraventricular Nucleus in Electroacupuncture Inhibiting Sympathetic Activities in Hypertensive Rats.

Authors:  Qi Zhang; Yingying Tan; Xin Wen; Fangfang Li
Journal:  Int J Hypertens       Date:  2022-01-18       Impact factor: 2.420

Review 4.  Role of Habenula in Social and Reproductive Behaviors in Fish: Comparison With Mammals.

Authors:  Satoshi Ogawa; Ishwar S Parhar
Journal:  Front Behav Neurosci       Date:  2022-02-10       Impact factor: 3.558

5.  Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients.

Authors:  HongYan Wei; JunYuan Gu; XueYao Jiang; Nan Deng; Jing Wu; LianHong Zou; YiMin Zhu; BoYu Tan
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

Review 6.  Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect.

Authors:  Wei-Can Chen; Yi-Bin Liu; Wei-Feng Liu; Ying-Ying Zhou; He-Fan He; Shu Lin
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

Review 7.  The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy.

Authors:  Hui-Min Liu; Le-le Ma; Chunyu Li; Bo Cao; Yifang Jiang; Li Han; Runchun Xu; Junzhi Lin; Dingkun Zhang
Journal:  Transl Oncol       Date:  2021-12-04       Impact factor: 4.243

8.  Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges.

Authors:  Carmine Zoccali; Alberto Ortiz; Inga Arune Blumbyte; Sarina Rudolf; Annette G Beck-Sickinger; Jolanta Malyszko; Goce Spasovski; Sol Carriazo; Davide Viggiano; Justina Kurganaite; Vaiva Sarkeviciene; Daiva Rastenyte; Andreja Figurek; Merita Rroji; Christopher Mayer; Mustapha Arici; Gianvito Martino; Gioacchino Tedeschi; Annette Bruchfeld; Belinda Spoto; Ivan Rychlik; Andrzej Wiecek; Mark Okusa; Giuseppe Remuzzi; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

9.  Serum Neuropeptide Y: A Potential Prognostic Marker of Intracerebral Hemorrhage.

Authors:  Weiming Sun; Zhenxing Zhang; Xu Feng; Xin Sui; Ye Miao
Journal:  Dis Markers       Date:  2021-08-10       Impact factor: 3.434

10.  Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem.

Authors:  Artur Pałasz; Piotr Żarczyński; Katarzyna Bogus; Kinga Mordecka-Chamera; Alessandra Della Vecchia; Jakub Skałbania; John J Worthington; Marek Krzystanek; Małgorzata Żarczyńska
Journal:  Pharmacol Rep       Date:  2021-04-29       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.